| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jan―29 |
Value of Emerging and Existing Pre-prophylaxis and Therapeutic Options for COVID-19 in Transplant Recipients: A Systematic Review of Economic Evaluations |
Alyssa Grant, Dima Kabbani, Andrew Vuong, Becky Skidmore, Amy T. Hsu, Geetha Sanmugalingham, Rienk de Vries, Sherrie Logan, Patricia Gongal, Caroline C. Piotrowski, Kednapa Thavorn |
| 2 |
[GO] |
2025―Apr―23 |
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in High-Risk Older Adults in Japan |
Hardik Goswami, Atsushi Tajima, Taizo Matsuki, Amy Puenpatom |
| 3 |
[GO] |
2025―Jan―31 |
COVID-19 Vaccine Preferences in China: A Comparison of Discrete Choice Experiment and Profile Case Best-Worst Scaling |
Enxue Chang, Yanni Jia, Xiaoying Zhu, Lunan Wang, Ying Yan, Kejun Liu, Weidong Huang |
| 4 |
[GO] |
2024―Nov―28 |
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey |
Sung Wook Kim, Caterina Alacevich, Catia Nicodemo, Raphael Wittenberg, Simon de Lusignan, Stavros Petrou |
| 5 |
[GO] |
2024―Jul―02 |
A Cost Evaluation of COVID-19 Remote Home Monitoring Services in England |
Sonila M. Tomini, Efthalia Massou, Nadia E. Crellin, Naomi J. Fulop, Theo Georghiou, Lauren Herlitz, Ian Litchfield, Pei Li Ng, Chris Sherlaw-Johnson, Manbinder S. Sidhu, Holly Walton, Stephen Morris |
| 6 |
[GO] |
2024―Mai―18 |
Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country |
Najmeh Moradi, Leila Zarei, Narges Hajimoladarvish, Zahra Meshkani, Marzieh Zanganeh, Jafar Babapour, Kamran Bagheri Lankarani |
| 7 |
[GO] |
2023―Mai―13 |
Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania |
Hiral Anil Shah, Tim Baker, Carl Otto Schell, August Kuwawenaruwa, Khamis Awadh, Karima Khalid, Angela Kairu, Vincent Were, Edwine Barasa, Peter Baker, Lorna Guinness |
| 8 |
[GO] |
2022―Aug―23 |
Public Preferences and Willingness to Pay for a COVID-19 Vaccine in Iran: A Discrete Choice Experiment |
Alireza Darrudi, Rajabali Daroudi, Masud Yunesian, Ali Akbari Sari |
| 9 |
[GO] |
2020―Dez―14 |
Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir’s Value |
Michaela R. Anderson, Peter B. Bach, Matthew R. Baldwin |
| 10 |
[GO] |
2020―Sep―03 |
How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton |
Laurence S. J. Roope, John Buckell, Frauke Becker, Paolo Candio, Mara Violato, Jody L. Sindelar, Adrian Barnett, Raymond Duch, Philip M. Clarke |
| 11 |
[GO] |
2020―Jul―04 |
The Cost Effectiveness of Stockpiling Drugs, Vaccines and Other Health Resources for Pandemic Preparedness |
Pedro Plans-Rubió |
| 12 |
[GO] |
2020―Apr―28 |
Group Testing for SARS-CoV-2: Forward to the Past? |
Koen B. Pouwels, Laurence S. J. Roope, Adrian Barnett, David J. Hunter, Terry M. Nolan, Philip M. Clarke |
| 13 |
[GO] |
2020―Apr―10 |
Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic |
Anthony J. Hatswell |
|
